To report a disease to the health district, you can access the Confidential Morbidity Report Portal (Epi-1) portal using the button above. Enter the information and click the checkmark at the bottom to submit. Healthcare professionals seeking additional information can visit VDH's pages on Disease Reporting for Medical Providers or Disease Reporting and Control Regulations.
Helpful Links
- Confidential Morbidity Report Portal (Epi-1)
- Healthcare-Associated Infections and Antimicrobial Resistance
- Tuberculosis
- Rabies Post-Exposure Prophylaxis Toolkit for Providers
- PWHD HPV Healthcare Provider Toolkit (published May 2016)
- For the latest information visit VDH's page on human papillomavirus (HPV)
- Personal Protective Equipment (PPE)
- Latest Guidance COVID-19 Guidance for Health Professionals and Healthcare Workers
Surveillance Data & Reports
Training
Chronic Pain Training Plan Now Available on TRAIN
Opioid abuse has increasingly become a serious public health issue over the past few years, with over 12 million people misusing prescription opioids in 2015. Providers' Clinical Support System for Opioid Therapies (PCSS-O) clinical experts, led by Roger Chou and Melissa B. Weimer, who have extensive knowledge in treating chronic pain, have developed a comprehensive core curriculum for primary care providers who want to have in-depth knowledge in this subject area. The curriculum gives up-to-date and evidence-based information on best opioid prescribing practices.
The PCSS-O curriculum, which provides clinicians with a solid base for treating chronic pain, is now on TRAIN as a nationally available training plan. It is the most comprehensive and up-to-date curriculum developed thus far for the treatment of chronic pain.
Funding for this initiative was made possible (in part) by grant no. 5H79TI025595-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.